SOST and sarcopenia: Univariate logistic regression analysis revealed that serum sclerostin was significantly associated with sarcopenia (estimate = 0.008, p = 0.045) but not osteoporosis (p = 0.257), suggesting its stronger relationship with muscle function than bone fragility (Table 3).